AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2024

Sep 12, 2024

34301_dirs_2024-09-12_0f2e6bea-5b6b-4738-af90-17fbc0ef58b9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2024-09-11

Reporting Person: Sims Andrew John Hugh MacIntyre (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-11	Stock Option (Right to Buy)	$1.26	A	46074	Acquired	2034-09-11	Common Stock (46074)	Direct

Footnotes

F1: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement.